I, Z. (2026). From Models to Medicines: A Narrative History and Regulatory Perspective on the Translational Impact of Model-Informed Drug Development (MIDD). Clinical and translational science, 19(5), e70547. https://doi.org/10.1111/cts.70547
Chicago Style (17th ed.) CitationI, Zineh. "From Models to Medicines: A Narrative History and Regulatory Perspective on the Translational Impact of Model-Informed Drug Development (MIDD)." Clinical and Translational Science 19, no. 5 (2026): e70547. https://doi.org/10.1111/cts.70547.
MLA (9th ed.) CitationI, Zineh. "From Models to Medicines: A Narrative History and Regulatory Perspective on the Translational Impact of Model-Informed Drug Development (MIDD)." Clinical and Translational Science, vol. 19, no. 5, 2026, p. e70547, https://doi.org/10.1111/cts.70547.